Ghost Tree Capital, LLC Intellia Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$23.82 - $32.8 $595,500 - $819,999
25,000 New
25,000 $687,000
Q1 2018

May 15, 2018
SELL
$19.43 - $34.95 $3.4 Million - $6.12 Million
-175,000 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$17.39 - $31.12 $3.04 Million - $5.45 Million
175,000
175,000 $3.36 Million

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email